+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Europe Facial Injectable Market Size was valued at USD 2.2 billion in 2022. The Europe Facial Injectable Market industry is projected to grow from USD 2.40 Billion in 2023 to USD 4.23 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.90% during the forecast period (2023 - 2032). Aging of the population, the rise in cosmetic procedures and aesthetic awareness, and the creation of affordable facial injectables are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Over the past ten years, the cosmetics business has experienced substantial growth. The overall number of non-surgical procedures has increased, including wrinkle relaxer and dermal filler injections, as a result of the rise in aesthetic appeal and accessibility of extremely difficult cosmetic procedures. The benefits of technology, including faster healing times, lower infection risks, less blood loss, and lower overall procedural costs, can be primarily credited for this development. The International Society of Aesthetic Plastic Surgery (ISAPS) estimates that more than 10,129,528 cosmetic surgery procedures were carried out in 2021. In 2021, calcium hydroxylapatite (222,785), poly-L-lactic acid (121,087), botulinum toxin, and hyaluronic acid will be the most popular non-surgical procedures. Due to the extensive use of face injectable procedures, the market is anticipated to grow over the course of the projected period.
The market is expanding because of the continually increasing senior population. For instance, according to a WHO forecast from 2021, one in six people globally will be 60 or older by 2030. The number of people in this age group will increase from 1 billion in 2020 to 1.4 billion by 2050. By 2050, there will be 2.2 billion people over the age of 60 on the planet. It is anticipated that between 2020 and 2050, the number of persons 80 and older would triple, reaching 426.0 million. Because this age is the main target for cosmetic procedures, the growing elderly population is anticipated to promote market growth throughout the forecast period. fuelling the market for facial injectables in Europe.Thus, driving the Europe Facial Injectable Market revenue.
The Europe Facial Injectable Market segmentation, based on type includes Hyaluronic Acid, Collagen, Botulinum Toxin, and Polymers and particles. With 34% of market revenue ($0.98 billion) coming from the hyaluronic acid sector, the market was dominated by this product. Hyaluronic acid-based solutions are increasingly in demand, partly due to their relative safety and longevity.
The Europe Facial Injectable Market segmentation, based on application, includes facial Surgery and Facial Uplift. The category that brought in the most money (60.4%) was face uplift. The significant presence of well-known businesses that cater to patients' needs and raise knowledge about how successful these treatments are at reducing lines and wrinkles is credited with the segment's rise.
The Europe Facial Injectable Market segmentation, based on end user, includes Hospitals, Clinics, and Research & Development Facilities. The hospital industry produced the largest revenue (46.4%). In the UK, for example, a number of hospitals and outpatient surgical centers provide these procedures to treat a range of skin conditions, such as the common signs of aging that develop around the forehead and eyes, such as frown lines, laughter lines, and crow's feet. The others segment is anticipated to grow at a slower CAGR throughout the projection period.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. Europe's Facial Injectable Market accounts for the second-largest market share. This is a result of the large number of cosmetic procedures and big industry participants' high expenditures on R&D. Further, In the European region, the German Facial Injectable market had the biggest market share, and the U.K. Facial Injectable market had the quickest rate of growth.
Germany dominated the region. Germany has a robust economy, which allows its citizens to have higher disposable incomes. This financial stability has enabled more people to afford facial injectable treatments, contributing to market growth.
France held the second-largest regional share. France attracts a significant number of cosmetic tourists seeking aesthetic treatments. Many people travel to France specifically for cosmetic procedures, including facial injectables, due to the country's renowned expertise in the field. This influx of tourists has boosted the demand for facial injectables in the French market.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Facial Injectable market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Facial Injectable sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Facial Injectable industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Facial Injectable sector.Major players in the Europe Facial Injectable Market, including Allergan Inc (Ireland), Merz Pharma (Germany), Ipsen (France), Valeant Pharmaceuticals (Canada), Galderma (Switzerland), Integra Lifesciences (Us), Tei Biosciences, Fibrogen (Finland), and Ethicon (Us), are attempting to increase market demand by investing in research and development operations.
In 1948, chemist Gavin S. Herbert founded the pharmaceutical company Allergan. It joined forces with the Irish pharmaceutical company Actavis plc in 2015 to establish Allergan plc, an American business with its main office in Ireland that develops, manufactures, and sells branded pharmaceuticals and medical devices for the eye, gastrointestinal, and the central nervous system. A worldwide pharmaceutical company with a focus on the development, manufacture, and marketing of branded pharmaceuticals, device, biologic, and biosimilar medicines, Allergan joined AbbVie in 2023. With its more than 30 products, Allergan tackles more than 60 ailments, including cancer, immunology, cosmetics, and eye care. They manufacture a variety of pharmaceutical products, such as Botox, which has both medical and cosmetic use. Allergan Aesthetics, a part of Allergan, develops, manufactures, and markets a selection of luxury brands and products for the face, body, cosmetic surgery, and skin care.
Merz Pharma, a privately held pharmaceutical company with affiliates throughout Europe, the United States, Canada, Mexico, Brazil, and Asia Pacific, was established in Frankfurt, Germany. Singapore and North Carolina, USA, both have regional offices. The company develops, tests, and distributes products for aesthetic medicine and neurologically induced movement disorders. Merz Aesthetics, a pioneer in aesthetic medicine, provides a vast selection of cutting-edge skin care products. Merz Therapeutics' goal is to provide for the unique needs of people with mobility challenges, neurological conditions, and other medical conditions. Merz Consumer Care sells products for wellness, beauty, and personal care under the tetesept and MerzSpezial brands. The company has spent more than 110 years developing solutions that improve the health and quality of life of people. The international, family-owned company Merz is comprised of the three businesses Merz Aesthetics, Merz Therapeutics, and Merz Consumer Care.
· Allergan Inc (Ireland)
· Merz Pharma (Germany)
· Ipsen (France)
· Valeant Pharmaceuticals (Canada)
· Galderma (Switzerland)
· Integra Lifesciences (Us)
· Tei Biosciences
· Fibrogen (Finland)
· Ethicon (Us)
April 2022: The FDA approved Revance Therapeutics, Inc.'s resubmitted Biologics Licence Application (BLA) for DaxibotulinumtoxinA for the treatment of moderate to severe glabellar lines.
March 2022: Allergan Aesthetics, a company owned by AbbVie, launched HArmonyCa with lidocaine in Europe. In this hybrid dual-effect injection, the two active ingredients are hyaluronic acid and calcium hydroxyapatite.
February 2022: Sinclair Pharma announced the acquisition of Viora. Thanks to this acquisition, the company is able to expand its presence in the market for medical aesthetics goods.
December 2021: The firm successfully concluded its acquisition of Soliton, Inc. in order to increase the range of non-invasive body contouring treatments offered by Allergan Aesthetics to include a treatment for the appearance of cellulite.
September 2021: Galderma and Sofregen have formed an exclusive partnership to develop the upcoming line of biostimulator fillers.
· Hyaluronic Acid
· Collagen
· Botulinum Toxin
· Polymers and Particles
· Facial Surgery
· Facial Uplift
· Hospitals
· Clinics
· Research and Development Facilities
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Report Scope
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 2.2 Billion |
|
Market Size 2023 |
USD 2.40 Billion |
|
Market Size 2032 |
USD 4.23 Billion |
|
Compound Annual Growth Rate (CAGR) |
7.8% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USDBillion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Type, Application, End User, and Region |
|
Geographies Covered |
Europe |
|
Countries Covered |
German, France, UK, Italy, Spain, |
|
Key Companies Profiled |
Allergan Inc (Ireland), Merz Pharma (Germany), Ipsen (France), Valeant Pharmaceuticals (Canada), Galderma (Switzerland), Integra Lifesciences (Us), Tei Biosciences, Fibrogen (Finland), Ethicon (Us) |
|
Key Market Opportunities |
The rising aesthetic consciousness and number of cosmetic procedures |
|
Key Market Dynamics |
The introduction of cost-effective facial injectables, and the aging population |
The Europe Facial Injectable Marketsize was valued at USD2.2Billion in 2022.
The market is projected to grow at a CAGR of 7.90% during the forecast period, 2023-2032.
Germany had the largest share in the market
The key players in the market are Allergan Inc (Ireland), Merz Pharma (Germany), Ipsen (France), Valeant Pharmaceuticals (Canada), Galderma (Switzerland), Integra Lifesciences (Us), Tei Biosciences, Fibrogen (Finland), Ethicon (Us).
The hyaluronic acid category dominated the market in 2022.
The hospitals had the largest share in the market.
Research on the market is done by industry professionals who provide personalized insights on the industry structure, market segmentation, Type assessment, competitive landscape (CL), along with penetration, and emerging trends. In addition to years of professional experience in their various fields and sectors, their analysis is largely based on primary interview (60%) and secondary research (40%) as well as years of professional experience. In addition, our researchers forecast the market's direction over the following seven years by examining past trends and the market's current position. Additionally, various trends of segments and categories that are geographically portrayed are studied and estimated using primary and secondary research.
The key level executives (VP, CEO, Marketing Directors, and Business Development Managers) of the major industry participants who are active and prominent as well as mid-scale businesses operating in this market were interviewed in-depth for this supply-side report by overall Global Market Research.
Extensive primary research was conducted to gain a deeper grasp of the market and industry. Both primary and secondary research, as well as years of pertinent professional experience, are used to support the analysis. By analyzing past and present market patterns, our experts were able to forecast the market's course over the following seven years. For the geographically offered categories in the list of market tables, it differs per category. In connection with the Global Market research report, we also conducted a number of primary interviews with senior level executives (VP, CEO's, Directors, Marketing Directors, Business Development Managers, CFOs, Technical Consultants, Key Opinion Leaders, Industry Experts, Decision Matrix Authorities, and other crucial individuals) of the key industry players who dominated the Global market.
The primary purpose of secondary research was to gather, identify, and validate the information necessary for the thorough, technical, market-focused, and commercial analysis of the global market. With the use of this study, it was also possible to classify and segment the market in accordance with market trends, geographic markets, and regional considerations linked to market type. Analysts have gathered data in the Distribution Channel for the study of the market from reliable sources including annual reports, journals, white papers, corporate presentations, company websites, international organizations of Energy and Power manufacturers, credible paid databases, and many others to gather reliable intel.
Both top-down and bottom-up methodologies were employed to assess the accuracy of the global market size. The market for as a whole was estimated using these methods for a number of different dependent submarkets. Secondary research was used to address the major industry players, and primary and secondary research was used to calculate their market shares in the various regions. This complete intellectual process includes reading the annual and financial reports of the top market participants and conducting in-depth interviews with top industry executives (VP, CEO, Marketing Directors, and Business Development Managers) to gain important industry insights.
Through reliable secondary sources and validated primary sources, the classification of the global markets and their geographic percentage splits were established. To obtain the final qualitative and quantitative data, all relevant variables that might have an impact on the market under investigation have been taken into consideration, inspected in great depth, verified through primary research, and assessed. This information was collected, added to, and thoroughly examined by professional analysts before being provided in this report. The process used to estimate the overall market size for this study is depicted in the following image as an example.
Report Code :
RL65279
Published on :
Sep 2023
Request a Free Sample Report
Speak to Analyst